Appaneal, Haley J.
LaPlante, Kerry L.
Lopes, Vrishali V.
Martin, Catherine
Puzniak, Laura
Wiemken, Timothy L.
Zasowski, Evan J.
McLaughlin, John M.
Caffrey, Aisling R. http://orcid.org/0000-0002-4180-027X
Funding for this research was provided by:
Pfizer
Article History
Received: 20 October 2023
Accepted: 15 December 2023
First Online: 13 January 2024
Declarations
:
: Haley J. Appaneal has received research funding from Pfizer. Aisling R. Caffrey has received research funding from AbbVie, Gilead, Merck, Pfizer, and Shionogi, and has been a speaker/advisor for Merck. No other conflicts to report. Kerry L. LaPlante has received research funding from Merck, AbbVie, and Pfizer and has been an advisor for Ferring Pharmaceuticals, AbbVie, and Seres Therapeutics. Catherine Martin, Laura Puzniak, Timothy L. Wiemken, Evan J. Zasowski, and John M. McLaughlin are employees and shareholders of Pfizer Inc.
: This study was determined to be exempt by the VA Providence Healthcare System (VAPHS) Institutional Review Board (IRB) and approved by the VAPHS Research and Development Committee. As this was a retrospective study of existing health records and exempt from IRB review, informed consent requirements are not applicable.